Dragan Grabulovski

Dragan Grabulovski is a pharmaceutical executive with over 25 years of experience in the industry. Dragan currently serves as an advisor at TOM Medications, and has previously held positions at Microcaps AG, Araris Biotech AG, TopPharm, Memo Therapeutics AG, ETH Zürich, BIOMUNEX PHARMACEUTICALS, and Grabulovski Consulting Services. Dragan also spent a year as the CSO of Covagen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Dragan has a wealth of experience in all aspects of the pharmaceutical industry, from drug discovery and development to commercialization and marketing. Dragan has played a key role in the successful launch of several new drugs, and their deep knowledge of the industry makes him a valuable asset to any company.

Dragan is a graduate of ETH Zürich, where they earned their Ph.D. in organic chemistry. Dragan has also completed post-doctoral fellowships at both Harvard University and the University of Zurich.

Dragan Grabulovski has a Ph D from ETH Zürich.